BCL6 and atherosclerosis: MiR-155 is upregulated in response to pro-inflammatory signals, promoting vascular inflammation and atherosclerosis by suppressing B-cell lymphoma 6 protein (Bcl6) in macrophages, thereby enhancing inflammatory responses.